Profile

Michael A. Kutcher, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

110 Ratings
8 Comments
 

Michael A. Kutcher, M.D.

Professor,

Clinical Interests

Peripheral Vascular Disease, Angioplasty, Cardiac Catheterization, Cardiology (clinical), Cardiology (interventional)

Contact Information

Request An Appointment

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-6674
Department: 336-716-2960

Insurance Accepted »

Related Links

Education & Training

  • B.S., St Francis College, 1970
  • M.D., Jefferson Medical College, 1974
  • Internship, Medicine, St Vincents Hsp/Med Ctr-Ny, 1975
  • Residency, Medicine, St Vincents Hsp/Med Ctr-Ny, 1978
  • Fellowship, Emory University School of Med, 1981

Board Certifications

  • American Board of Internal Medicine, Cardiovascular Disease
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Interventional Cardiology

Memberships

  • American College of Cardiology
  • Am Coll Of Physicians
  • Am Federation Of Clinical Rese
  • Am Heart Association
  • Forsyth-Davie-Stokes Medical S
  • Hlth Sciences Communications A

NPI Number

  • 1568447845
Michael A. Kutcher, M.D.

Doctor Rating

4.6 out of 5

110 Ratings
8 Comments
 

Michael A. Kutcher, M.D.

Professor, Cardiology

Research Interests

Drug-Eluting Stents; Myocardial Infarction; Stents; Coronary Artery Disease; Coronary Restenosis
More »

Contact Information

Request An Appointment

Academic: 336-716-2960 | Department: 336-716-2960

Related Links

Recent Publications

The impact of bleeding avoidance strategies on hospital-level variation in bleeding rates following percutaneous coronary intervention: insights from the National Cardiovascular Data Registry CathPCI Registry. Vora AN, Peterson ED, McCoy LA, Garratt KN, Kutcher MA, Marso SP, Roe MT, Messenger JC, Rao SV.. JACC Cardiovasc Interv. 2016;9(8):771-779.

Response to letter regarding article, 'the learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry' [letter]. Hess CN, Peterson ED, Neely ML, Dai D, Hillegass WB, Krucoff MW, Kutcher MA, Messenger JC, Pancholy S, Piana RN, Rao SV.. Circulation. 2015;131(8):e358.

Highlights of the Scottsdale Interventional Forum 2014, how-to symposiums: advances in chronic total occlusion therapy. Lazkani M, Eddin M, Lombardi WL, Kutcher M, Rizik D, Pershad A.. J Invasive Cardiol. 2015;27(2):E30-E34.

SCAI core curriculum for adult and pediatric interventional fellowship training in continuous quality assessment and improvement. Jennings HS III, Rao SV, Feldman DN, Kolansky DM, Kutcher MA, Baker NC, Chambers CE, Petit CJ, Cigarroa JE.. Catheter Cardiovasc Interv. 2015;86(3):422-431.

Door-to-balloon time as a process metric for treatment of ST-segment elevation myocardial infarction: time to 'tap out'? [editorial]. Kutcher MA.. JACC Cardiovasc Interv. 2015;8(15):1975-1977.

Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry. Kutcher MA, Brennan JM, Rao SV, Dai D, Anstrom KJ, Mustafa N, Sedrakayan A, Booth ME, Douglas PS, Messenger JC.. Catheter Cardiovasc Interv. 2014;83(2):171-181.

Comparison of percutaneous coronary intervention for previously treated versus de novo culprit lesions in acute myocardial infarction patients: insights from the National Cardiovascular Data Registry. Chin CT, Messenger JC, Dai D, McCoy LA, Kutcher MA, Anderson HV, Roe MT, Wang TY.. Am Heart J. 2014;167(3):393-400.

The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry. Hess CN, Peterson ED, Neely ML, Dai D, Hillegass WB, Krucoff MW, Kutcher MA, Messenger JC, Pancholy S, Piana RN, Rao SV.. Circulation. 2014;129(22):2277-2286.

Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Riley RF, Newby LK, Don CW, Roe MT, Holmes DN, Gandhi SK, Kutcher MA, Herrington DM.. Am Heart J. 2013;165(1):50-56.

Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry. Mulukutla SR, Marroquin OC, Vlachos HA, Selzer F, Toma C, Kip KE, Abbott JD, Holper E, Lee JS, Khandhar S, Kutcher M, Kelsey S, Smith C, Faxon D, Williams DO.. Am J Cardiol. 2013;111(4):486-492.

Gender differences in vascular complications associated with transfemoral and transradial cardiac catheterization and PCI: a single-center experience [abstract]. Anderson J, Sacrinty M, Turner S, Gandhi S, Santos R, Kutcher M, Little W, Applegate R.. J Am Coll Cardiol. 2013;61(10 Suppl):E77.

Cost effectiveness of Everolimus-eluting compared to propensity score matched bare metal stenting: an analysis of a selected stent strategy [abstract]. Applegate RJ, Sacrinty M, Gandhi S, Kutcher M, Santos R, Little W.. J Am Coll Cardiol. 2013;61(10 Suppl):E1505.

Peak troponin I greater than 5 times the 99th percentile after PCI does not define a high-risk group [abstract]. Butler M, Sacrinty M, Little W, Applegate R, Kutcher M, Santos R, Gandhi S.. J Am Coll Cardiol. 2013;61(10 Suppl):E1879.

The 'final voyage' of the Endeavor stent [editorial comment]. Kutcher MA.. JACC Cardiovasc Interv. 2013;6(5):513-515.

Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention. Applegate R, Sacrinty M, Schafer P, Smith J, Gandhi S, Kutcher M, Santos R, Cecile A, Little W.. Catheter Cardiovasc Interv. 2013;82(4):E375-E384.

Guidelines-based treatment of anaemic STEMI patients: practice patterns and effects on in-hospital mortality: a retrospective analysis from the NCDR. Riley RF, Newby LK, Don CW, Alexander KP, Peterson ED, Peng SA, Gandhi SK, Kutcher MA, Amsterdam EA, Herrington DM.. Europ Heart J Acute Cardiovasc Care. 2013;2(1):35-43.

Association between admission hemoglobin level and guideline-based therapy in patients with ST-segment elevation myocardial infarction: an analysis from the NCDR [abstract]. Riley RF, Newby LK, Don C, Gandhi S, Alexander K, Peng SA, Kutcher M, Amsterdam E, Herrington D.. J Am Coll Cardiol. 2012;59(13 Suppl):E1817.

Timing of electrocardiographic diagnosis in ST-segment elevation myocardial infarction patients with an initial non-diagnostic electrocardiogram: an observational analysis from the NCDR [abstract]. Riley RF, Newby LK, Don C, Roe M, Holmes DN, DaJuanicia N, Gandhi S, Kutcher M, Herrington D.. J Am Coll Cardiol. 2012;59(13 Suppl):E418.

Cost-effectiveness analysis of propensity matched radial and femoral cardiac catheterization and coronary intervention [abstract]. Schafer P, Sacrinty MT, Smith JW, Little W, Gandhi S, Kutcher M, Santos R, Smith T, Cecile AC, Applegate R.. J Am Coll Cardiol. 2012;59(13 Suppl):E72.

Transitioning to the radial artery as the preferred access site for cardiac catheterization: an academic medical center experience. Turner S, Sacrinty M, Manogue M, Little W, Gandhi S, Kutcher M, Santos R, Applegate R.. Catheter Cardiovasc Interv. 2012;80(2):247-257.

Contrast use and acute kidney injury in contemporary clinical practice [abstract]. Applegate R, Sacrinty M, Allem J, Gandhi S, Kutcher M, Santos R, Smith T, Little W.. J Am Coll Cardiol. 2012;60(17 Suppl B):B39-B40.

Cost effectiveness of Everolimus-eluting stents compared to first generation drug-eluting stents in contemporary clinical practice [abstract]. Applegate R, Sacrinty M, Gandhi S, Kutcher M, Santos R, Smith T, Little W.. J Am Coll Cardiol. 2012;60(17 Suppl B):B185.

Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice. Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ.. Circ Cardiovasc Qual Outcomes. 2011;4(4):408-415.

Bleeding avoidance strategy: transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest academic medical center experience [abstract]. Manogue MR, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Turner SJ, Applegate RJ.. J Am Coll Cardiol. 2011;57(14 Suppl 1):E1057.

Cost effectiveness of drug-eluting stents versus bare metal stents in clinical practice: effect of stent length and diameter [abstract]. Schafer P, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Applegate RJ.. J Am Coll Cardiol. 2011;57(14 Suppl 1):E1184.

Cath lab utilization during transition to the radial artery as preferred access: the Wake Forest academic medical center experience [abstract]. Turner S, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Manogue MR, Applegate RJ.. J Am Coll Cardiol. 2011;57(14 Suppl):E1269.

Second-generation everolimus-eluting stents: and the beat goes on? [editorial comment]. Kutcher MA.. JACC Cardiovasc Interv. 2011;4(11):1216-1217.

Resource utilization for propensity matched radial and femoral catheterization and intervention [abstract]. Schafer PE, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Cecile AC, Applegate RJ.. J Am Coll Cardiol. 2011;58(20 Suppl B):B146-B147.

Percutaneous coronary intervention at centers with and without on-site surgery: a meta-analysis. Singh M, Holmes DR Jr, Dehmer GJ, Lennon RJ, Wharton TP, Kutcher MA, Aversano T, Rihal CS.. JAMA. 2011;306(22):2487-2494.

Trends and predictors of length of stay after primary percutaneous coronary intervention: a report from the CathPCI registry. Chin CT, Weintraub WS, Dai D, Mehta RH, Rumsfeld JS, Anderson HV, Messenger JC, Kutcher MA, Peterson ED, Brindis RG, Rao SV.. Am Heart J. 2011;162(6):1052-1061.

Cardiac magnetic resonance imaging to assess and predict improvement of myocardial function after percutaneous coronary intervention: a new standard? [editorial comment]. Kutcher MA.. JACC Cardiovasc Interv. 2010;3(4):401-402.

Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes. Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.. J Invasive Cardiol. 2010;22(6):266-270.

Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC.. Circ Cardiovasc Interv. 2009;2(1):35-42.

3-year comparison of drug-eluting versus bare-metal stents. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC.. J Am Coll Cardiol Intv. 2009;2(3):231-239.

Three-year comparison of drug-eluting versus bare metal stents [abstract]. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC.. J Am Coll Cardiol. 2009;53(10 Suppl 1):A353.

Clinical outcomes of bare metal stents versus drug-eluting stents target vessel revascularization: evidence for a high-risk bare metal stent cohort [abstract]. Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.. J Am Coll Cardiol. 2009;53(10 Suppl 1):A317-A318.

Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC.. Am Heart J. 2009;157(4):688-694.

Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction [abstract]. Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC.. J Am Coll Cardiol. 2009;53(10 Suppl 1):A319.

Drug-eluting stent versus bare metal stent use in patients with chronic kidney disease [abstract]. Santos RM, Sacrinty MJ, Kutcher MA, Gandhi SK, Little WC, Applegate RJ.. J Am Coll Cardiol. 2009;53(10 Suppl 1):A393-A394.

Prognostic implications of vascular complications following PCI. Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R.. Catheter Cardiovasc Interv. 2009;74(1):64-73.

Percutaneous coronary interventions in facilities without cardiac surgery on site: a report from the National Cardiovascular Data Registry (NCDR). Kutcher MA, Klein LW, Ou F-S, Wharton TP Jr, Dehmer GJ, Singh M, Anderson HV, Rumsfeld JS, Weintraub WS, Shaw RE, et al.. J Am Coll Cardiol. 2009;54(1):16-24.

Drug-eluting stents versus bypass surgery for multivessel coronary disease. Kutcher MA.. Curr Cardiovasc Risk Rep. 2009;3():331-338.

ST-segment-elevation myocardial infarction treated at hospitals with and without on-site cardiac surgery: do we have the answer and what about the future? [editorial]. Dehmer GJ, Kutcher MA.. Circ Cardiovasc Interv. 2009;2(6):497-499.

'Off-label' stent therapy: 2-year comparison of drug-eluting versus bare-metal stents. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC.. J Am Coll Cardiol. 2008;51(6):607-614.

Culprit vessel PCI versus traditional cath and PCI for STEMI. Applegate RJ, Graham SH, Gandhi SK, Kutcher MA, Sacrinty MT, Santos RM, Little WC.. J Invasive Cardiol. 2008;20(5):224-228.

Drug-eluting stents versus bare metal stents in saphenous vein grafts at 2 years [abstract]. Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.. J Am Coll Cardiol. 2008;51(10 Suppl B):B78.

Drug-eluting stents for ST elevation myocardial infarction: evidence for benefit at two years [abstract]. Gandhi SK, Kay JD, Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Little WC.. J Am Coll Cardiol. 2008;51(10 Suppl B):B1.

Culprit vessel primary percutaneous coronary intervention for ST elevation myocardial infarction shorter door to balloon time [abstract]. Graham SH, Applegate RJ, Gandhi SK, Sacrinty MT, Baki TT, Santos RM, Little WC, Kutcher MA.. J Am Coll Cardiol. 2008;51(10 Suppl B):B61.

Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC.. J Am Coll Cardiol Intv. 2008;1(3):317-326.

Percutaneous coronary interventions at facilities without on-site cardiac surgery: a report from the National Cardiovascular Data Registry (NCDR) [abstract]. Kutcher MA, Klein LW, Wharton TP Jr, Singh M, Dehmer GJ, Anderson V, Rumsfeld JS, Weintraub WS, Peterson ED, Ohu F-S, et al.. Circulation. 2008;117(21):e432.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Cardiology

Clinical Interests

Peripheral Vascular Disease, Angioplasty, Cardiac Catheterization, Cardiology (clinical), Cardiology (interventional)
Michael A. Kutcher, M.D.

Michael A. Kutcher, M.D.

Professor, Cardiology

Request An Appointment

Doctor Rating

4.6 out of 5

Michael A. Kutcher, M.D.110 Ratings
8 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.6
CP efforts to include in decisions
4.5
CP explanations of prob/condition
4.6
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.5
Likelihood of recommending CP
4.6
Patients' confidence in CP
4.7
Time CP spent with patient
4.4
Wait time at clinic
4.3



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/31/2016

I had no worries.

5/5/2016

Excellent Physician

4/26/2016

He showed concern and willingness to help and answer my questions.

3/15/2016

All staff were very good to excellent! However *Dr. Kutcher was not user friendly. He is very good but had no people skills when dealing with my wife and little when dealing with me. I do not plan to keep him as my dr. going forward. I have had a good experience other than *Dr. Kutcher's abruptness.

2/25/2016

good

12/17/2015

good experience!

12/10/2015

*Dr. Kutcher, I'm sure is competent in his field, however, his personality resembles that of a cobra.

9/1/2015

I would recommend *Dr. Kutcher to anyone needing excellent heart care!

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.